Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. MABCAMPATH (alemtuzumab)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

MABCAMPATH (alemtuzumab)

Medicine - Posted on Sep 17 2009 - Updated on Jun 12 2019
Active substance (DCI)
  • alemtuzumab
history (2)
  • 9/17/08

    MABCAMPATH

    Progrès thérapeutique mineur dans la prise en charge en première ligne de la leucémie lymphoïde chronique à cellules B lorsq...
    CAV :
    54321
    icône flèche
  • 1/9/02

    MABCAMPATH 10mg/ml, solution à diluer pour perfusion (boîte de 3 ampoules)

    MABCAMPATH 10mg/ml, solution à diluer pour perfusion (boîte de 3 ampoules)
    icône flèche
Technical information
ATC code
  • L01XC04
Manufacturer
BAYER SANTE – Division Bayer Schering Pharma
Presentation

MABCAMPATH 30mg/ml, solution à diluer pour perfusion
B/3 flacons - Code CIP : 565 837-1

All our publications
    Drug therapy Hematologic cancers

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
15uQyxZnF1HHNb67